SpaceX falls below its IPO price
Digest more
Reports of delayed IPOs for major AI labs—such as OpenAI—are bullish for the broader market, according to Wells Fargo Equity Research. The analysts argue that postponed public listings will prompt AI companies to pivot back toward driving user adoption ...
Generic drug giant Apotex Health Corp.‘s dominance of the domestic pharmaceutical market is one of the reasons analysts are citing for their bullish stock recommendations as they initiate coverage of the newly public company.
Excitement around the upcoming market debut of SpaceX has spurred the exchange-traded-fund industry to plan new ETFs that will that give traders a way to make risky leveraged bets on the company’s stock after its initial public offering. After Elon Musk ...
SpaceX is set to have its initial public offering (IPO) on June 12, and the company's public debut is set to be a big test for the market. The company recently announced it had lowered its target valuation by roughly $200 billion, but it is still planning ...
